GPs warned to monitor patients taking SGLT2 inhibitors Related items from OnMedica Diabetes drugs not linked to bladder cancer Long-acting GLP-1 agonists for type 2 diabetes Diabetes drug could protect against Parkinson’s disease Yellow Card scheme goes mobile with first app |
No comments:
Post a Comment